Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx(TM) Insertable Cardiac Monitor System

First ICM device with remote programming paired with dual-stage arrhythmia detection algorithm MARLBOROUGH, Mass., June 29, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (... Devices, Cardiology, Monitoring, FDA Boston Scientific, LUX-Dx, Insertable Cardiac Monitor, arrhythmia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news